Sialyl-Tn serves as a potential therapeutic target for ovarian cancer

• Main Authors: Linah Al-Alem (Author), Jillian M. Prendergast (Author), Justin Clark (Author), Bianca Zarrella (Author), Dominique T. Zarrella (Author), Sarah J. Hill (Author), Whitfield B. Growdon (Author), Venkatesh Pooladanda (Author), David R. Spriggs (Author), Daniel Cramer (Author), Kevin M. Elias (Author), Rawan I. Nazer (Author), Steven J. Skates (Author), Jeff Behrens (Author), Daniel T. Dransfield (Author), Bo R. Rueda (Author)
• Format: Book
• Published: BMC, 2024-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Ovarian cancer remains the deadliest of the gynecologic cancers in the United States. There have been limited advances in treatment strategies that have seen marked increases in overall survival. Thus, it is essential to continue developing and validating new treatment strategies...